{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:15:20Z","timestamp":1779106520387,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,18]]},"DOI":"10.7759\/cureus.109094","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:37:45Z","timestamp":1779104265000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Concurrent Amiodarone and Beta-Blocker Therapy at Discharge With 30-Day Rehospitalization After Atrial Fibrillation Hospitalization"],"prefix":"10.7759","author":[{"given":"Teddy A","family":"Teddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer","family":"Cadet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edidiong","family":"Okon-Ben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraol T","family":"Erega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelwahab","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri","family":"Vummaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Marzoug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendall","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr6243","article-title":"Impact of chronic obstructive pulmonary disease burden on patients with atrial fibrillation: a nationwide study","volume":"17","author":"Eltawansy S","year":"2025","unstructured":"Eltawansy S, Ahmed F, Sharma G, et al.. Impact of chronic obstructive pulmonary disease burden on patients with atrial fibrillation: a nationwide study. J Clin Med Res. 2025, 17:309-319. 10.14740\/jocmr6243","journal-title":"J Clin Med Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2024.12.018","article-title":"Comparison of the latest ESC, ACC\/AHA\/ACCP\/HRS, and CCS guidelines on the management of atrial fibrillation","volume":"11","author":"Wolfes J","year":"2025","unstructured":"Wolfes J, Ellermann C, Frommeyer G, Eckardt L. Comparison of the latest ESC, ACC\/AHA\/ACCP\/HRS, and CCS guidelines on the management of atrial fibrillation. JACC Clin Electrophysiol. 2025, 11:836-849. 10.1016\/j.jacep.2024.12.018","journal-title":"JACC Clin Electrophysiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-023-00642-w","article-title":"Antiarrhythmic treatment in heart failure","volume":"21","author":"K\u00f6nemann H","year":"2024","unstructured":"K\u00f6nemann H, G\u00fcler-Eren S, Ellermann C, Frommeyer G, Eckardt L. Antiarrhythmic treatment in heart failure. Curr Heart Fail Rep. 2024, 21:22-32. 10.1007\/s11897-023-00642-w","journal-title":"Curr Heart Fail Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators","volume":"342","author":"Roy D","year":"2000","unstructured":"Roy D, Talajic M, Dorian P, et al.. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000, 342:913-920. 10.1056\/NEJM200003303421302","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh BN","year":"2005","unstructured":"Singh BN, Singh SN, Reda DJ, et al.. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med. 2005, 352:1861-1872. 10.1056\/NEJMoa041705","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1516126","article-title":"A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX","volume":"16","author":"Ludwig RJ","year":"2025","unstructured":"Ludwig RJ, Anson M, Zirpel H, et al.. A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX. Front Pharmacol. 2025, 16:1516126. 10.3389\/fphar.2025.1516126","journal-title":"Front Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson ME","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40:373-383. 10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin PC","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011, 46:399-424. 10.1080\/00273171.2011.568786","journal-title":"Multivariate Behav Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1197\/j.aem.2004.11.018","article-title":"Advanced statistics: bootstrapping confidence intervals for statistics with \"difficult\" distributions","volume":"12","author":"Haukoos JS","year":"2005","unstructured":"Haukoos JS, Lewis RJ. Advanced statistics: bootstrapping confidence intervals for statistics with \"difficult\" distributions. Acad Emerg Med. 2005, 12:360-365. 10.1197\/j.aem.2004.11.018","journal-title":"Acad Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12182","article-title":"Methods for constructing and assessing propensity scores","volume":"49","author":"Garrido MM","year":"2014","unstructured":"Garrido MM, Kelley AS, Paris J, Roza K, Meier DE, Morrison RS, Aldridge MD. Methods for constructing and assessing propensity scores. Health Serv Res. 2014, 49:1701-1720. 10.1111\/1475-6773.12182","journal-title":"Health Serv Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2016.03.003","article-title":"Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications","volume":"13","author":"Siontis KC","year":"2016","unstructured":"Siontis KC, Gersh BJ, Killian JM, et al.. Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications. Heart Rhythm. 2016, 13:1418-1424. 10.1016\/j.hrthm.2016.03.003","journal-title":"Heart Rhythm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.022388","article-title":"National trends in atrial fibrillation hospitalization, readmission, and mortality for Medicare beneficiaries, 1999-2013","volume":"135","author":"Freeman JV","year":"2017","unstructured":"Freeman JV, Wang Y, Akar J, Desai N, Krumholz H. National trends in atrial fibrillation hospitalization, readmission, and mortality for Medicare beneficiaries, 1999-2013. Circulation. 2017, 135:1227-1239. 10.1161\/CIRCULATIONAHA.116.022388","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv304","article-title":"A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network\/European Heart Rhythm Association consensus conference","volume":"18","author":"Kirchhof P","year":"2016","unstructured":"Kirchhof P, Breithardt G, Bax J, et al.. A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network\/European Heart Rhythm Association consensus conference. Europace. 2016, 18:37-50. 10.1093\/europace\/euv304","journal-title":"Europace"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly SJ","year":"2011","unstructured":"Connolly SJ, Camm AJ, Halperin JL, et al.. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med. 2011, 365:2268-2276. 10.1056\/NEJMoa1109867","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.06.033","article-title":"Atrial fibrillation in heart failure: a comprehensive review","volume":"123","author":"Deedwania PC","year":"2010","unstructured":"Deedwania PC, Lardizabal JA. Atrial fibrillation in heart failure: a comprehensive review. Am J Med. 2010, 123:198-204. 10.1016\/j.amjmed.2009.06.033","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association","volume":"137","author":"Chen LY","year":"2018","unstructured":"Chen LY, Chung MK, Allen LA, et al.. Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association. Circulation. 2018, 137:e623-e644. 10.1161\/CIR.0000000000000568","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eur102","article-title":"Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study","volume":"13","author":"Torp-Pedersen C","year":"2011","unstructured":"Torp-Pedersen C, Crijns HJ, Gaudin C, Page RL, Connolly SJ, Hohnloser SH. Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study. Europace. 2011, 13:1118-1126. 10.1093\/europace\/eur102","journal-title":"Europace"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof P","year":"2020","unstructured":"Kirchhof P, Camm AJ, Goette A, et al.. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020, 383:1305-1316. 10.1056\/NEJMoa2019422","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy GH","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB, et al.. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005, 352:225-237. 10.1056\/NEJMoa043399","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse DG","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP, et al.. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002, 347:1825-1833. 10.1056\/NEJMoa021328","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer DL","year":"2019","unstructured":"Packer DL, Mark DB, Robb RA, et al.. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019, 321:1261-1274. 10.1001\/jama.2019.0693","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.37349\/ent.2026.1004148","article-title":"Factor XI inhibitors versus direct oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of efficacy and safety","volume":"6","author":"Parizad R","year":"2026","unstructured":"Parizad R, Hatwal J, Bodagh H, Batta A, Mohan B. Factor XI inhibitors versus direct oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of efficacy and safety. Explor Neuroprot Ther. 2026, 6:1004148. 10.37349\/ent.2026.1004148","journal-title":"Explor Neuroprot Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2026.04.006","article-title":"Frailty and advanced age in atrial fibrillation: Implications for treatment strategies and clinical outcomes - a systematic review","author":"Batta A","year":"2026","unstructured":"Batta A, Parizad R, Hatwal J, Mittal A, Goyal MK, Mohan B. Frailty and advanced age in atrial fibrillation: Implications for treatment strategies and clinical outcomes - a systematic review. Indian Heart J. 2026, 10.1016\/j.ihj.2026.04.006","journal-title":"Indian Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485804-association-of-concurrent-amiodarone-and-beta-blocker-therapy-at-discharge-with-30-day-rehospitalization-after-atrial-fibrillation-hospitalization","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:37:46Z","timestamp":1779104266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485804-association-of-concurrent-amiodarone-and-beta-blocker-therapy-at-discharge-with-30-day-rehospitalization-after-atrial-fibrillation-hospitalization"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.109094","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}